Special Research Report (RNVA)

Rennova Health, Inc. (RNVA) Named One of The Most Undervalued Stocks of 2023 By The Stock Day Podcast

At Stock Day Media, we’ve named Rennova Health, Inc. (RNVA) as one of the most undervalued stocks of 2023 on the OTC Markets. From its low stock price to its positive cash flow and significant revenue potential, investors will want to learn more about this uniquely positioned company in the healthcare industry.

About Rennova, Health Inc.

Headquartered in West Palm Beach, Florida, Rennova Health, Inc. is a company dedicated to delivering efficient, innovative, and accessible healthcare services to rural communities. Rennova currently owns one operating hospital, Big South Fork Medical Center, located in Oneida and a rural clinic in Kentucky, Tennessee, as well as an additional hospital and a physician’s practice located in Jamestown, Tennessee, which are both slated to reopen.

Rennova has recently taken strides to further diversify its offerings. With the formation of Myrtle Recovery Centers, Rennova will also be able to provide comprehensive care for individuals with substance, behavioral, and mental health challenges as the demand for these services continues to grow.

Rennova also made the decision to separate its former technology and software division into InnovaQor, Inc.(INQR), a company dedicated to creating innovative technology solutions that allow medical providers and facilities to effectively enhance their business and processes, while protecting their assets and patient data.

Share Structure and Revenue Potential

Currently, we estimate that Rennova Health, Inc. is now generating in excess of $15 million in revenues annually from its Big South Fork Medical Center with a positive cash flow on a monthly basis. Rennova is expected to continue growing its revenues and could add another $10 million annually from its Myrtle Recovery Centers division, which it expects to open in the second quarter. Additionally, with the capacity for 25 medical beds, 40 mental health beds, plus operational surgical facilities, Rennova is targeting a 2024 reopening of its Jamestown, Tennessee regional hospital. This hospital previously had revenues of approximately $1.2 to $1.5 million per month.

Yet, despite its positive cash flow, proven revenue generation, and the potential for significant revenue additions, Rennova Health, Inc. is currently a triple zero stock with a market cap of just $3 million, earning the company a spot as one of Stock Day’s most undervalued stocks of 2023.

InnovaQor Investment

However, none of the above includes Rennova Health. Inc.’s significant investment in its former technology and software division, InnovaQor, Inc., which is now a fully reporting public company trading on the OTC Markets under the ticker symbol ‘INQR’. At Stock Day Media, we believe this investment could provide additional returns for Rennova, and it has previously been intimated that Rennova shareholders may receive shares in InnovaQor from Rennova.

While InnovaQor continues its efforts to raise funding to execute on its business plans, the company has published significant news regarding the securement of a signed agreement with XCPCNL Business Services Corporation (OTC:XCPL) to develop a sales and marketing strategy for its healthcare software products and services. On February 28th, 2023, InnovaQor also announced the launch of its automated billing solution through its subsidiary, Medical Mime, Inc., a provider of an EHR (Electronic Health Records) software designed for behavioral health and substance abuse facilities.

Market Demand

In determining their business model and diversification strategy, it is clear that Rennova Health, Inc. is well positioned to meet not only the needs of its communities but also the evolving demands of the healthcare industry.

According to the American Hospital Association, nearly 20% of Americans live in rural areas and depend on their hospitals as important – and often only – sources of care in their communities. Meanwhile, The U.S. behavioral health market size was valued at USD 76.44 billion in 2021 and is projected to grow from USD 79.69 billion in 2022 to USD 105.14 billion by 2029, according to Fortune Business Insights.

For Rennova, the proven demand for improved access to rural healthcare, as well as the increasing need for behavioral health services, adds both strength and opportunity to their business strategy, representing significant potential for investors and shareholders.

Learn More About Rennova, Health Inc. (RNVA) Today!

With its triple zero status, significant revenues, and positive cash flow, it’s easy to see why we’ve named Rennova Health, Inc. as one of 2023’s most undervalued stocks. However, with a number of exciting projects set to launch this year, it is Rennova’s upcoming revenue potential and diversified offerings that makes this company a blatant standout among other companies listed on the OTC Market in the healthcare services industry.

To learn more about this undervalued stock, please listen to Rennova’s latest podcast interview, here.

Stock Day Media may receive direct compensation of $500 to $10,000 for content and or advertisements, that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933.
X
Search
Generic filters